These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8962194)

  • 1. In vivo mechanism of action of leflunomide: selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3085. PubMed ID: 8962194
    [No Abstract]   [Full Text] [Related]  

  • 2. Leflunomide-mediated tolerance of B lymphocytes for T-independent xenoantigens needs the presence of these xenoantigens.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1997; 29(1-2):1304. PubMed ID: 9123317
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):952. PubMed ID: 8623477
    [No Abstract]   [Full Text] [Related]  

  • 4. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 5. Leflunomide derivative FK778 inhibits production of antibodies in an experimental model of alloreactive T-B cell interaction.
    Ramos-Barrón MA; Gómez-Alamillo C; Santiuste I; Agüeros C; Cosme LS; Benito A; Gimenez T; Merino J; Merino R; Arias M
    Exp Clin Transplant; 2009 Dec; 7(4):218-24. PubMed ID: 20353370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
    Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466
    [No Abstract]   [Full Text] [Related]  

  • 7. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts.
    Lin Y; Vandeputte M; Waer M
    J Immunol; 1998 Jan; 160(1):369-75. PubMed ID: 9551993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB.
    Imose M; Nagaki M; Kimura K; Takai S; Imao M; Naiki T; Osawa Y; Asano T; Hayashi H; Moriwaki H
    Hepatology; 2004 Nov; 40(5):1160-9. PubMed ID: 15455409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice.
    Lagodziński Z; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):121-5. PubMed ID: 1804041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of B cell function by the immunosuppressive agent leflunomide.
    Siemasko KF; Chong AS; Williams JW; Bremer EG; Finnegan A
    Transplantation; 1996 Feb; 61(4):635-42. PubMed ID: 8610393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU; Kurrle R
    Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.
    Papageorgiou C; Albert R; Andersen E; Zurini M; Hungerford V; Floersheim P; Schreier MH
    Transplant Proc; 2001 May; 33(3):2263-5. PubMed ID: 11377522
    [No Abstract]   [Full Text] [Related]  

  • 13. Brazilein, an important immunosuppressive component from Caesalpinia sappan L.
    Ye M; Xie WD; Lei F; Meng Z; Zhao YN; Su H; Du LJ
    Int Immunopharmacol; 2006 Mar; 6(3):426-32. PubMed ID: 16428078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide.
    Ulrichs K; Kaitschick J; Bartlett R; Müller-Ruchholtz W
    Transplant Proc; 1992 Apr; 24(2):718-9. PubMed ID: 1566498
    [No Abstract]   [Full Text] [Related]  

  • 15. Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.
    Zhang L; Qi Z; Wu D; Shan S; Ekberg H
    Scand J Immunol; 2004 Mar; 59(3):255-60. PubMed ID: 15030575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and synthesis of new immunosuppressive alkaloids from the stem of Fissistigma oldhamii (Hemsl.) Merr.
    Zhang YN; Zhong XG; Zheng ZP; Hu XD; Zuo JP; Hu LH
    Bioorg Med Chem; 2007 Jan; 15(2):988-96. PubMed ID: 17081761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Didemnin B: an immunosuppressive cyclic peptide that stimulates murine antibody responses in vivo and in vitro.
    Montgomery DW; Celniker A; Zukoski CF
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1295-6. PubMed ID: 3274320
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current concepts concerning immune tolerance].
    Artsimovich NG; Nastoiashchaia NN
    Usp Sovrem Biol; 1976; 82(6):403-16. PubMed ID: 798437
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sensitivity of the splenic immunocompetent cells of mice with different genotypes to the action of alkylating agents].
    Pevnitskiĭ LA; Telegin LIu; Ir KN
    Biull Eksp Biol Med; 1985 Aug; 100(8):213-5. PubMed ID: 3875371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of malononitriloamide analogs of leflunomide on whole blood lymphocyte stimulation in humans, rhesus macaques, cats, dogs, and rats.
    Gregory CR; Silva HT; Patz JD; Morris RE
    Transplant Proc; 1998 Jun; 30(4):1047-8. PubMed ID: 9636423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.